title: Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia.
authors.forename: Radjesh J
authors.initials: RJ
authors.lastname: Bisoendial
authors.forename: G Kees
authors.initials: GK
authors.lastname: Hovingh
authors.forename: Karim
authors.initials: K
authors.lastname: El Harchaoui
authors.forename: Johannes H M
authors.initials: JH
authors.lastname: Levels
authors.forename: Sotirios
authors.initials: S
authors.lastname: Tsimikas
authors.forename: Kewei
authors.initials: K
authors.lastname: Pu
authors.forename: Aeilko E
authors.initials: AE
authors.lastname: Zwinderman
authors.forename: Jan Albert
authors.initials: JA
authors.lastname: Kuivenhoven
authors.forename: John J P
authors.initials: JJ
authors.lastname: Kastelein
authors.forename: Erik S G
authors.initials: ES
authors.lastname: Stroes
mesh_terms: D000328:Adult; D000577:Amides; D002352:Carrier Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D053480:Cholesterol Ester Transfer Proteins; D004952:Esters; D005260:Female; D006023:Glycoproteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D013438:Sulfhydryl Compounds / Q000008:administration & dosage*; D013631:Tangier Disease / Q000188:drug therapy* / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D000577:Amides; C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D004952:Esters; D006023:Glycoproteins; D013438:Sulfhydryl Compounds; C411602:dalcetrapib; D002784:Cholesterol